In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

The company, which has licensed the CRISPR-based technology from Philadelphia ... Khalili is a named inventor on patents that cover the viral gene editing technology and also holds equity ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and possible regeneration.

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...